Trend Results : American College of Cardiology

Blog Post Results (1-20 of 266)


CT scans reveal reduced leaflet motion after aortic valve replacement

(American College of Cardiology) About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots around the valve leaflets (known as subclinical leaflet thrombosis) that reduced the motion of the valves, according to an observational study presented at the American College of Cardiology's 66th Annual Scientific Session.

Embol-X and CardioGard do not reduce overall number of brain lesions, may affect size

(American College of Cardiology) Two FDA-cleared medical devices designed to remove potential vessel-blocking debris particles from the bloodstream during aortic valve replacement, known as Embol-X and CardioGard, did not significantly...Show More Summary

Closing left atrial appendage reduces stroke risk from AFib

(American College of Cardiology) For patients with atrial fibrillation (AFib), a common heart rhythm disorder, closing the area of the heart known as the left atrial appendage as an add-on procedure during cardiac surgery was associated...Show More Summary

Blood test can detect heart damage after non-cardiac surgery

(American College of Cardiology) A blood test for a protein called high-sensitivity troponin T, which is released into the bloodstream when injury to the heart occurs, can identify patients with heart damage after non-cardiac surgery...Show More Summary

Use of levosimendan with heart-lung machine fails to improve outcomes

(American College of Cardiology) When used as a preventive measure during heart surgery, the heart failure drug levosimendan did not significantly reduce rates of death, heart attack, kidney dialysis or use of a mechanical assist device...Show More Summary

Heart procedure linked with bleeding in the brain, neurological impairment

(American College of Cardiology) Small leakages from blood vessels in the brain, known as microbleeds, increase with age and are associated with cognitive decline. Of 84 older patients undergoing transcatheter aortic valve replacement...Show More Summary

For atrial fibrillation ablation, newer anticoagulant reduces major bleeds

(American College of Cardiology) Uninterrupted treatment with dabigatran, a non-vitamin K antagonist oral anticoagulant (NOACs), before, during and after ablation to treat atrial fibrillation significantly reduced the incidence of major...Show More Summary

New study adds to concerns about heightened risk of death for AFib patients taking digoxin

(American College of Cardiology) Patients with atrial fibrillation (AFib) who are given digoxin to control their symptoms have an increased risk of death, whether or not they have a diagnosis of heart failure, compared with patientsShow More Summary

Pacemaker program can reduce dangerous fainting episodes

(American College of Cardiology) Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing program designed to detect and stop the abnormal heart rhythms that precede syncope had a seven-fold reduction...Show More Summary

Genetically guided warfarin dosing lowers risk of some adverse events

(American College of Cardiology) Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse events compared with clinically...Show More Summary

Outcomes for Absorb stent acceptable at 1 to 2 years, with caveats

(American College of Cardiology) Patients receiving the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), a dissolving stent to open clogged vessels around the heart, showed outcomes comparable with patients receiving the Xience drug-eluting metal stent between years one and two. Show More Summary

PCI, drugs equally beneficial for treating fully blocked arteries

(American College of Cardiology) This study shows percutaneous coronary intervention is not needed in all cases.

No evidence of cognitive issues when evolocumab added to statin therapy

(American College of Cardiology) There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes memory loss or other problems with cognition or thinking, according to findings from the EBBINGHAUS study, the largest, most rigorously designed study to address this issue to date. Show More Summary

Guidelines differ on recommendations of statin treatment for African-Americans

(The JAMA Network Journals) Approximately 1 in 4 African-American individuals recommended for statin therapy under guidelines from the American College of Cardiology/American Heart Association are no longer recommended for statin therapy...Show More Summary

High-risk pulmonary embolism patients often go without most effective treatments

(University of Pennsylvania School of Medicine) In a new study presented today at the American College of Cardiology 66th Annual Scientific Session, researchers from the Perelman School of Medicine at the University of Pennsylvania have...Show More Summary

Minneapolis Heart Institute physician receives American College of Cardiology top honor

(Allina Health ) Cardiologist will receive the Douglas P. Zipes Distinguished Young Scientist Award for his commitment to improving patient care. His achievements will be recognized Sunday at the American College of Cardiology conference in Washington, DC.

Transcatheter Aortic Valve Replacement as Effective as Surgery in Intermediate Patients

Medtronic plc (NYSE: MDT) today unveiled first-ever clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial, which was presented at the American College of Cardiology (ACC) 66th Annual Scientific Session and published simultaneously in The New England Journal of Medicine (NEJM) (1).

Atrial fibrillation patients may safely discontinue blood thinners after successful ablation

(University of Pennsylvania School of Medicine) In new study presented today at the American College of Cardiology 66th Annual Scientific Session, researchers from the Perelman School of Medicine at the University of Pennsylvania have found that patients with persistent AF, who are successfully treated with ablation many, in fact, no longer need blood thinners.

Self-expanding TAVR as good as surgery in intermediate-risk patients

(American College of Cardiology) Two-year data reveal no difference in the combined rate of stroke and death from any cause when comparing the use of self-expanding transcatheter aortic valve replacement (TAVR) with standard open-heart...Show More Summary

PCSK9 inhibition with bococizumab yields mixed results

(American College of Cardiology) In a clinical program that was terminated early, the experimental PCSK9 inhibitor bococizumab, when given on top of effective statin therapy, had widely varying effects on LDL cholesterol levels and had no benefit on cardiovascular events among those with LDL lower than 100 mg/dL. Show More Summary

Copyright © 2015 Regator, LLC